Synergistic inhibitory effects of transplatin and β-hydroxyisovalerylshikon on carcinoma A431 cells involve epidermal growth factor receptorYING XU; NAKAJO, Shigeo; NAKAYA, Kazuyasu et al.Cancer letters. 2002, Vol 188, Num 1-2, pp 67-72, issn 0304-3835, 6 p.Article

DNA interactions of new antitumor platinum complexes with trans geometry activated by a 2-metylbutylamine or sec-butylamine ligandPROKOP, Radim; KASPARKOVA, Jana; NOVAKOVA, Olga et al.Biochemical pharmacology. 2004, Vol 67, Num 6, pp 1097-1109, issn 0006-2952, 13 p.Article

Inelastic Neutron Scattering Study of Pt Complexes Displaying Anticancer PropertiesBATISTA DE CARVALHO, Luís A. E; MARQUES, M. Paula M; MARTIN, Christine et al.ChemPhysChem (Print). 2011, Vol 12, Num 7, pp 1334-1341, issn 1439-4235, 8 p.Article

Plasmodium falciparum: DNA sequence specificity of cisplatin and cisplatin analoguesMURRAY, Vincent; CAMPBELL, Heather M; GERO, Annette M et al.Experimental parasitology. 2011, Vol 128, Num 4, pp 396-400, issn 0014-4894, 5 p.Article

DNA interactions of platinum anticancer drugs. Recent advances and mechanisms of actionBRABEC, Viktor; KASPARKOVA, Jana.Metal compounds in cancer chemotherapy. 2005, pp 187-218, isbn 81-7736-277-1, 1Vol, 32 p.Book Chapter

Interaction of poly(I)•poly(C) with trans-dichloro-diammine-platinum (II)HERMANN, D; FAZAKERLEY, G. V; HOUSSIER, C et al.Biopolymers. 1984, Vol 23, Num 5, pp 945-960, issn 0006-3525Article

Proton-NMR study of the interaction of trans-dichloro-diamine-platinum(II) with poly(I) and poly(I)•poly(C)FAZAKERLEY, G. V; HERMANN, D; GUSCHLBAUER, W et al.Biopolymers. 1984, Vol 23, Num 5, pp 961-972, issn 0006-3525Article

The effect of platinum derivatives on interfacial properties of DNAKASPAROVA, D; VRANA, O; KLEINWACHTER, V et al.Biophysical chemistry. 1987, Vol 28, Num 3, pp 191-197, issn 0301-4622Article

Platinum anticancer drug binding to DNA detected by thickness-shear-mode acoustic wave sensorHONGBO SU; WILLIAMS, P; THOMPSON, M et al.Analytical chemistry (Washington, DC). 1995, Vol 67, Num 5, pp 1010-1013, issn 0003-2700Article

Differences in the inhibition of translation by cisplatin, transplatin, and certain related compoundsSATO, P. H; ROSENBERG, J. M; SATO, R. I et al.Biochemical pharmacology. 1996, Vol 52, Num 12, pp 1895-1902, issn 0006-2952Article

Transplatin blocks voltage-dependent calcium current in isolated cochlear outer hair cells but is not ototoxic in vivoSAITO, T; YAMAMOTO, T; ZHI JIANG ZHANG et al.Brain research. 1995, Vol 697, Num 1-2, pp 276-279, issn 0006-8993Article

Nephrotoxicity of cisplatin, carboplatin and transplatin. A comparative in vitro studyHANNEMANN, J; BAUMANN, K.Archives of toxicology. 1990, Vol 64, Num 5, pp 393-400, issn 0340-5761, 8 p.Article

Cisplatin, transplatin, and their hydrated complexes : separation and identification using porous graphitic carbon and electrospray ionization mass spectrometryEHRSSON, H. C; WALLIN, I. B; ANDERSSON, A. S et al.Analytical chemistry (Washington, DC). 1995, Vol 67, Num 19, pp 3608-3611, issn 0003-2700Article

Detection of proteins that recognize platinum-modified DNA using gel mobiligy shift assayFUJIWARA, Y; KASAHARA, K; SUGIMOTO, Y et al.Japanese journal of cancer research. 1990, Vol 81, Num 12, pp 1210-1213, issn 0910-5050Article

Inhibition of lactate-dehydrogenase by cisplatin and other platinum-compounds: enzyme leakage of LDH is not a suitable method to measure platinum-compound-induced kidney cell damage in vitroHANNEMANN, J; BAUMANN, K.Research communications in chemical pathology and pharmacology. 1988, Vol 60, Num 3, pp 371-379, issn 0034-5164Article

Oligonucléotides modifiés par le transplatine et modulation de l'expression génétique = Transplatin-modified oligonucleotides as modulators of gene expressionBoudvillain, Marc; Leng, Marc.1996, 132 p.Thesis

Crosslinking of tRNA containing a long extra arm to elongation factor tu by trans-diamminedichloroplatinum(II)RASMUSSEN, N.-J; WILMAN, F. P; CLARK, B. F. C et al.Nucleic acids research. 1990, Vol 18, Num 16, pp 4883-4890, issn 0305-1048, 8 p.Article

Evidence for similar structural changes on binding of platimun anti-tumor agents to DNA and nucleosomesMARZILLI, L. G; REILY, M. D; HEYL, B. L et al.FEBS letters. 1984, Vol 176, Num 2, pp 389-392, issn 0014-5793Article

Characterization of the mutational specificity of DNA cross-linking mutagens by the Lac⁺ reversion assay with Escherichia coliOHTA, Toshihiro; OHMAE, Satoru; YAMAYA, Kaori et al.Teratogenesis, carcinogenesis, and mutagenesis. 2001, Vol 21, Num 4, pp 275-282, issn 0270-3211Article

Réactivité du transplatine avec l'ADN: relation avec son inactivité thérapeutique = Reactivity of transplatin with DNA: relation with its clinical inactivityDalbies, Rozenn; Leng, M.1995, 122 p.Thesis

Platinum complex-induced dysfunction of cultured renal proximal tubule cells : a comparative study of carboplatin and transplatin with cisplatinCOURJAULT, F; LEROY, D; COQUERY, I et al.Archives of toxicology. 1993, Vol 67, Num 5, pp 338-346, issn 0340-5761Article

LE TRANSPLATINE : UN AGENT PONTANT DES ACIDES NUCLEIQUES EN DOUBLE ET TRIPLE HELICE = TRANSPLATIN : A CROSS-LINKING REAGENT IN NUCLEIC ACIDS IN DOUBLE AND TRIPLE HELIXColombier, Caroline; Leng, Marc.1998, 3 vol., 456 pThesis

Iron-and ascorbic acid-induced lipid peroxidation in renal microsomes isolated from rats treated with platinum compoundsHANNEMANN, J; DUWE, J; BAUMANN, K et al.Cancer chemotherapy and pharmacology. 1991, Vol 28, Num 6, pp 427-433, issn 0344-5704Article

Promotion of trans-platinum in vivo effects on renal heme and hemoprotein metabolism by d,l-buthionine-S,R-sulfoximineMAYER, R. D; MAINES, M. D.Biochemical pharmacology. 1990, Vol 39, Num 10, pp 1565-1571, issn 0006-2952Article

Metallothioneins and Platinum(II) Anti-Tumor CompoundsKNIPP, Markus.Current medicinal chemistry. 2009, Vol 16, Num 5, pp 522-537, issn 0929-8673, 16 p.Article